Cardiovascular disease is the leading cause of death worldwide. Achieving the next phase
of potential treatment strategies and better prognostic tools will require a concerted effort …

Human pluripotent stem cells (PSCs) represent an attractive source of cardiomyocytes with
potential applications including disease modeling, drug discovery and safety screening, and …

This may be the most exciting time ever for the field of tissue engineering and regenerative
medicine (TERM). After decades of progress, it has matured, integrated, and diversified into …

Cell therapy has attracted considerable interest as a promising therapeutic alternative for
patients with Parkinson's disease (PD). Clinical studies have shown that grafted fetal neural …

Highlights•Human embryonic stem cell (hESC) can be derived from a single eight-cell
embryo blastomere.•hESC can be derived, expanded, and maintained in defined, xeno-free …

In Japan, a research center network consisting of Kyoto University to provide clinical-grade
induced Pluripotent Stem Cells (iPSC) and several major research centers to develop iPSC …

Stem cell therapy is a promising approach to the treatment of ischemic heart disease via
replenishing cell loss after myocardial infarction. Both preclinical studies and clinical trials …

Stem cells and their differentiated progeny offer great hope for treating disease by providing
an unlimited source of cells for repairing or replacing damaged tissue. Initial studies …

Clinically discarded human embryos, which are generated from both normal and abnormal
fertilizations, have the potential of developing into blastocysts. A total of 1,649 discarded …

Pluripotent stem cells (PSCs) can differentiate into virtually any cell type in the body, making
them attractive for both regenerative medicine and drug discovery. Over the past 10 years …